
Gearing Up For SCALE 2023 With Co-Director, Michael Gold, MD
Gold encourages all attendees to feel welcome as they attend both cosmetic and medical dermatology sessions.
Dermatology professionals from across the country are meeting together again, this time for the
Dermatology Times: Can you provide an overview of the upcoming SCALE meeting and what attendees can look forward to?
Gold: SCALE is in its 18th year, and it has become one of the most recognized meetings in the United States, and even globally. And what we want to bring to the table is showcasing what's out there by the best of the best faculty in the business. We have aesthetic and cosmetic dermatology, medical dermatology, as well as plastic surgery. We have some of the best faculty, and we don't want it to be the same lectures that you can get anywhere. We want people to bring new ideas and new concepts to the table, while still being very science-based. We've spent time making sure that we're not talking about topics that don’t have relevance in everyday practice. We want to know what's the latest FDA-approved treatment for a specific disease state and how do we get there, on both the aesthetic side and on the medical dermatology side as well.
We have over 90 faculty members. When talking about SCALE, I always tell attendees that our faculty is available. They're not going to hide and run. Additionally, Nashville is appealing; we hope people will enjoy coming to this city that has exploded in popularity. We will have about 140 to 150 exhibitors, as well as receptions with those exhibitors and the best music. We have somebody who's going to be singing all of Johnny Cash’s music one evening, as well as another fantastic country music band. SCALE is meant to be family-oriented, but still scientific. We are all about teaching and educating. And that's what makes SCALE so special.
Dermatology Times: What can attendees expect regarding medical and cosmetic dermatology topics at SCALE?
Gold: The medical dermatology component of SCALE has grown dramatically as our understanding of medical dermatology diseases has grown. And, again, the faculty that we have are the researchers. These are the people that do the work and understand the diseases. At the end of the day, we want the attendees to know what the newest treatments are, what the newest therapies are, how to use them, and what to look out for. We also have several sessions where we're going to do live treatments with injectables and devices and show how to use skincare after the devices. A lot of these are new; you're not going to see the same thing that you might see somewhere else. Especially in the live demo, I'm probably showing 4 or 5 new things that people have never seen before, which is exciting. It makes us discuss how do these [technologies] fit into our space and what does that mean for everybody? I think that's important. We’ll talk about some of the newest FDA-cleared devices, new injectables and how to use them properly, and how we combine techniques.
We also have 2 programs on Wednesday, May 17th, one is an anatomy course run by
We’ve built into the program other panels and discussions from the social media world with some experts from the practice management teams.
Also on the medical dermatology side, we have a panel that I put together this year on exosomes, which seems to be the hottest topic. It's run by
Dermatology Times: You are also speaking on quite a few topics at SCALE, what will your presentations cover?
Gold: I'm mainly going to discuss devices. We have great medicines for acne, eczema, psoriasis, and vitiligo, but we also have devices for all these. There has been an explosion of devices recently. So, I’m going to talk about the science based on what has been done with these, do they work, how do they work, how do they target the specific areas that we're treating, and how do we incorporate them into our practices? Because when you bring devices in, it becomes cash-based, which can be a little bit different for some, but it’s doable.
In the acne world, we have several new devices that have become very popular, so I want to cover those. I want to make sure people understand how they work and what their mechanisms of action are. The same goes for psoriasis, there are new devices that we're using as adjuncts for our patients' therapies.
I’m also doing a talk on skin care; I like to call it “skincare potpourri.” I've been dispensing skincare products for almost 30 years. I work with a lot of companies in doing their clinical research. And I think that's where I fit into giving patients the product and explaining the science behind the product. You can decide if it's something you want to use, but I'm going to tell you how we got from A to B.
Dermatology Times: Do you have any closing thoughts about SCALE 2023?
Gold: I'm biased, obviously, but SCALE is the meeting of the year. We want to make it an environment where every facet whether you're dermatology, plastic, ocular plastic, medical dermatology, med spa owner, or a med spa worker, everyone feels comfortable. SCALE is for everyone. We want everybody to feel welcome and to feel that they get something out of it at the end of the day. And at the same time, I want our industry colleagues who are our supporters to feel that they have been able to do their educational part and that they can get value out of being at a meeting. There are so many meetings in our space that you have to differentiate because they can't be everywhere at the same time. So, we put a great deal of effort into working with our industry partners. Hopefully at the end of the day, they're as happy as we are.
For more information on sessions and faculty members at SCALE,
[This conversation has been edited for space and clarity.]
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















